Complete Filing Data
Brag House Holdings, Inc. reported Stockholders Equity of $3.43 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Brag House Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cost of Revenue * | $464.00 | $34.8K | |
| Net Income Loss | -$15.9M | -$3.3M | -$4.7M |
| Selling General And Administrative Expense | $3.3M | $608.9K | $1.1M |
| Research And Development Expense | $23.6K | $21.0K | $24.1K |
| Operating Expenses | $7.7M | $1.5M | $2.3M |
| Nonoperating Income Expense | -$8.2M | -$1.8M | $2.7M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$15.9M | -$3.3M | -$4.7M |
| Comprehensive Income Net Of Tax | -$15.9M | -$3.3M | -$4.7M |
| Other Nonoperating Income | $210.7K | $384.0K | |
| Revenues | $105.00 | $366.4K | |
| Gross Profit | -$359.00 | $331.6K | |
| Interest Expense Nonoperating | $1.5M | $2.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Cost of Revenue * | $464.00 | |||||
| Net Income Loss | $2.5M | -$1.7M | -$1.1M | -$1.0M | -$957.0K | -$1.0M |
| Selling General And Administrative Expense | $713.4K | $624.5K | $257.2K | $113.6K | $151.4K | $122.6K |
| Research And Development Expense | $457.00 | $777.00 | $386.00 | $6.1K | $2.0K | $10.9K |
| Operating Expenses | $1.6M | $1.6M | $584.5K | $549.4K | $408.6K | $232.0K |
| Nonoperating Income Expense | $4.2M | -$63.5K | -$483.2K | -$460.6K | -$478.4K | -$801.7K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $2.5M | -$1.7M | -$1.1M | -$1.0M | -$887.0K | -$1.0M |
| Comprehensive Income Net Of Tax | $2.5M | -$1.7M | -$1.1M | -$1.0M | -$957.0K | -$1.0M |
| Other Nonoperating Income | $91.1K | $69.7K | $1.6K | $244.2K | $471.00 | $567.00 |
| Revenues | $55.00 | |||||
| Gross Profit | -$409.00 | |||||
| Interest Expense Nonoperating | $438.7K | $704.2K | $478.8K | $802.2K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | $3.4M | -$8.5M | -$6.1M | -$2.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $222.6K | $29.2K | $33.9K | $560.4K |
| Common Stock Value | $2.1K | $14.6K | $14.8K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $193.3K | -$4.7K | -$526.5K | |
| Amortization Of Debt Discount Premium | $100.8K | $50.6K | $462.2K | |
| Retained Earnings Accumulated Deficit | -$30.5M | -$14.6M | -$11.4M | |
| Other Liabilities Current | $98.2K | $95.2K | $238.00 | |
| Liabilities Current | $7.4M | $9.8M | $6.8M | |
| Liabilities And Stockholders Equity | $14.8M | $1.3M | $718.6K | |
| Assets Noncurrent | $2.1M | $1.2M | $619.5K | |
| Assets Current | $12.7M | $82.2K | $99.1K | |
| Assets | $14.8M | $1.3M | $718.6K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$15.2K | -$15.2K | -$15.2K | |
| Accrued Liabilities Current | $1.1M | $193.8K | $645.9K | |
| Accounts Payable Current | $1.3M | $1.9M | $953.2K | |
| Other Receivables Net Current | $34.7K | $34.7K | ||
| Other Assets Current | $25.5K | $18.3K | $30.6K | |
| Repayments Of Notes Payable | $399.1K | $25.0K | ||
| Accrued Payroll Taxes Current | $44.2K | $251.0K | $47.3K | |
| Stockholders Equity Note Subscriptions Receivable | $3.7K | $4.3K | ||
| Deferred Costs | $1.0M | $1.2M | $610.8K | |
| Accrued Interest | $826.2K | $299.0K | ||
| Share Payable Current | $1.2K | $32.5K | $251.1K | |
| Preferred Stock Value | $420.00 | $420.00 | ||
| Liabilities | $11.4M | $9.8M | $6.8M | |
| Convertible Debt Net Of Discount And Issuance Costs | $5.7M | $4.5M | ||
| Interest Payable Current | $1.2M | |||
| Notes Payable Current | $297.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $16.6M | $900.7K | $1.6M | -$8.2M | -$7.5M | -$7.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $9.6M | $1.5M | $3.5M | $19.9K | $8.2K | $163.1K |
| Common Stock Value | $1.1K | $15.3K | $15.3K | $351.4K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $3.4M | $129.2K | ||||
| Amortization Of Debt Discount Premium | $100.8K | $5.1K | ||||
| Retained Earnings Accumulated Deficit | -$14.9M | -$17.4M | -$15.7M | |||
| Other Liabilities Current | $102.6K | $95.0K | $95.0K | |||
| Liabilities Current | $1.6M | $1.4M | $2.1M | |||
| Liabilities And Stockholders Equity | $18.2M | $2.3M | $3.7M | |||
| Assets Noncurrent | $8.5M | $389.2K | $160.3K | |||
| Assets Current | $9.7M | $1.9M | $3.5M | |||
| Assets | $18.2M | $2.3M | $3.7M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$15.2K | -$15.2K | -$15.2K | |||
| Accrued Liabilities Current | $107.7K | $52.4K | $102.4K | |||
| Accounts Payable Current | $1.2M | $1.2M | $1.3M | |||
| Other Receivables Net Current | $35.5K | $46.3K | $68.6K | |||
| Other Assets Current | $15.0K | $43.7K | ||||
| Repayments Of Notes Payable | $273.6K | |||||
| Accrued Payroll Taxes Current | $41.4K | $46.9K | ||||
| Stockholders Equity Note Subscriptions Receivable | $3.7K | $3.7K | ||||
| Deferred Costs | ||||||
| Accrued Interest | ||||||
| Share Payable Current | $221.4K | $6.7K | $213.9K | |||
| Preferred Stock Value | ||||||
| Liabilities | $1.6M | $1.4M | $2.1M | |||
| Convertible Debt Net Of Discount And Issuance Costs | ||||||
| Interest Payable Current | $141.1K | |||||
| Notes Payable Current | $125.5K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2020 |
|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $963.5K | $179.8K | ||
| Share Based Compensation | $963.5K | $179.8K | $556.2K | |
| Proceeds From Issuance Of Common Stock | $5.9M | $100.0K | $22.00 | |
| Net Cash Provided By Used In Operating Activities | -$6.6M | -$570.0K | -$777.0K | |
| Net Cash Provided By Used In Financing Activities | $23.0M | $565.4K | $250.5K | |
| Increase Decrease In Due To Related Parties | -$24.3K | $14.7K | -$34.0K | |
| Increase Decrease In Accrued Salaries | -$206.8K | $203.7K | -$3.3K | |
| Increase Decrease In Accrued Liabilities | $1.1M | -$567.1K | $37.5K | |
| Increase Decrease In Accounts Payable | -$609.0K | $489.4K | $451.3K | |
| Proceeds From Convertible Debt | $105.0K | $169.1K | $252.5K | |
| Increase Decrease In Share Payable | -$6.3K | |||
| Increase Decrease In Other Current Assets | $25.5K | -$12.2K | $28.7K | |
| Proceeds From Notes Payable | $101.7K | $321.4K | ||
| Increase Decrease In Other Current Liabilities | $3.0K | $95.0K | ||
| Payments Of Stock Issuance Costs | $2.0K | |||
| Increase Decrease In Other Receivables | -$35.5K | $34.7K | ||
| Net Cash Provided By Used In Investing Activities | -$16.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $344.6K | $313.1K | $42.5K | $45.0K | $46.0K | $46.0K |
| Share Based Compensation | $344.6K | $313.1K | $42.5K | $45.0K | $46.0K | $46.0K |
| Proceeds From Issuance Of Common Stock | $6.8M | |||||
| Net Cash Provided By Used In Operating Activities | -$1.8M | $56.3K | ||||
| Net Cash Provided By Used In Financing Activities | $5.2M | $72.8K | ||||
| Increase Decrease In Due To Related Parties | -$21.4K | $6.6K | ||||
| Increase Decrease In Accrued Salaries | -$204.1K | $54.6K | ||||
| Increase Decrease In Accrued Liabilities | $23.6K | -$17.8K | ||||
| Increase Decrease In Accounts Payable | -$673.5K | $91.6K | ||||
| Proceeds From Convertible Debt | $105.0K | $72.8K | ||||
| Increase Decrease In Share Payable | $181.4K | $107.4K | ||||
| Increase Decrease In Other Current Assets | ||||||
| Proceeds From Notes Payable | $101.7K | |||||
| Increase Decrease In Other Current Liabilities | -$220.00 | |||||
| Payments Of Stock Issuance Costs | $117.9K | |||||
| Increase Decrease In Other Receivables | $15.8K | |||||
| Net Cash Provided By Used In Investing Activities |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 12.2M | 5.7M | 5.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 12.2M | 5.7M | 5.6M |
| Earnings Per Share Diluted | $-1.31 | $-0.58 | $-0.84 |
| Earnings Per Share Basic | $-1.31 | $-0.58 | $-0.84 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 21.0M | 7.0M | 5.7M |
| Common Stock Shares Issued | 21.0M | 7.0M | 5.7M |
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 82.1K | 82.1K |
| Preferred Stock Shares Issued | 0.00 | 82.1K | 82.1K |
| Preferred Stock Shares Authorized | 24.8M | 24.8M | 24.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 10.8M | 10.8M | 7.7M | 5.7M | 5.6M | 5.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 26.1M | 10.8M | 7.7M | 5.7M | 5.6M | 5.6M |
| Earnings Per Share Diluted | $0.10 | $-0.16 | $-0.14 | $-0.18 | $-0.17 | $-0.18 |
| Earnings Per Share Basic | $0.23 | $-0.16 | $-0.14 | $-0.18 | $-0.17 | $-0.18 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 11.0M | 10.8M | 10.7M | |||
| Common Stock Shares Issued | 11.0M | 10.8M | 10.7M | |||
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 24.8M | 24.8M | 24.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Legal Fees | $2.1M | $490.5K | $321.5K |
| Marketing And Advertising Expense | $641.9K | $173.0K | $311.4K |
| Foreign Currency Transaction Gain Loss Before Tax | $441.00 | -$1.8K | |
| Stock Issued During Period Value Issued For Services | $964.1K | $125.00 | |
| Loan Extension Fees | $997.3K | $1.9M | |
| Interest Paid Net | $532.9K | $25.0K | |
| Amortization Of Financing Costs And Discounts | -$2.2M | -$2.8M | |
| Adjustments To Additional Paid In Capital Offering Costs | -$1.4M | ||
| Software Expense | $639.3K | $18.1K | |
| Stock Issued During Period Value Conversion Of Convertible Securities | $6.8M | ||
| Stock Issued During Period Value Net Of Offering Costs | $5.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Legal Fees | $374.9K | $330.4K | $138.3K | $224.5K | $209.3K | $52.5K |
| Marketing And Advertising Expense | $182.2K | $212.3K | $81.5K | $160.3K | ||
| Foreign Currency Transaction Gain Loss Before Tax | -$14.00 | $140.00 | $311.00 | -$616.00 | -$152.00 | |
| Stock Issued During Period Value Issued For Services | $50.0K | $164.6K | ||||
| Loan Extension Fees | $307.9K | $689.4K | ||||
| Interest Paid Net | $376.4K | |||||
| Amortization Of Financing Costs And Discounts | ||||||
| Adjustments To Additional Paid In Capital Offering Costs | -$1.4M | -$5.0K | ||||
| Software Expense | $14.9K | $160.7K | $64.7K | |||
| Stock Issued During Period Value Conversion Of Convertible Securities | $154.4K | $6.6M | ||||
| Stock Issued During Period Value Net Of Offering Costs | $5.6M |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.